http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2169195-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab8082c05551818c0e34872b0e0d71b6 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-385 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104 |
| filingDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec71c560d37fb98dbf06d9ec6734b481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5065e4a99190429699b5ee2a2ec2495a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0356b52d2b8b4fb11034ab4f1e7da04 |
| publicationDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2169195-C2 |
| titleOfInvention | Strain of bacterium pseudomonas aeruginosa 5271 used for preparing vaccine against fur wild animals pseudomonosis |
| abstract | FIELD: biotechnology, veterinary science. SUBSTANCE: invention relates to production of vaccine preparations against pyocyanic infection in fur wild animals, preferably in polar foxes and foxes. Strain of bacterium Pseudomonas aeruginosa 527 1 is deposited in collection of strains that are pathogens of diseases in fur wild animals of museum of bacterial and viral cultures of Science-Research institute of fur farming and rabbit breeding (NIIPZK) named for V. A. Afanasiev and has registration number 527 1 . Strain relates to serovariant 06. Strain is cultured in Marten's broth or synthetic medium at 32 C for 18-20 h at constant shaking. After control of grown culture for toxicogenicity and proteolytic activity bacterial mass is separated and inactivated and then aluminum hydroxide is added as an adjuvant and packaged. Invention ensures to prevent the concealed loss in reproduction of fur wild animals in farms with pyocyanic infection being independently of serological pattern of pathogen. EFFECT: strain indicated above, enhanced effectiveness of vaccine. 3 ex |
| priorityDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.